Lantern Pharma to Host Third Quarter 2025 Results Webcast
Lantern Pharma Inc. (NASDAQ: LTRN), a pioneering company in artificial intelligence used for cancer therapy development, will announce its third quarter 2025 operating and financial results via a webcast. This event is scheduled for Thursday, November 13 at 9:00 a.m. Eastern Time / 6:00 a.m. Pacific Time.
Details of the Webcast
The upcoming webcast promises to provide a comprehensive overview of the company's performance during the third quarter, specifically focusing on the period ended September 30, 2025. Key discussions will cover operational results, financial insights, and guidance on future milestones and developments.
Management Team Engagement
During the call, Panna Sharma, the President and CEO of Lantern Pharma, will be at the forefront, joined by other critical members of the management team. Their insights will reflect on the company's strategic direction and share details about their AI platform, RADR®. This platform embodies their commitment to enhancing the drug development process for cancer therapies.
How to Participate
To participate in the webcast, interested parties can register through the provided Zoom link in advance. This ensures that stakeholders gain real-time insights into the company's performance as well as future strategies.
About Lantern Pharma
Lantern Pharma leverages its RADR® platform, integrating cutting-edge AI and machine learning technologies into the discovery, development, and commercialization of innovative cancer therapies. The focus remains on optimizing the development timelines while enhancing therapeutic opportunities and patient outcomes.
Visit Our Website for More Information
For details about the company and its initiatives, please visit their official website. Regular updates and information can be found there to keep investors informed about Lantern Pharma's progress.
Frequently Asked Questions
When is the Lantern Pharma Q3 2025 results webcast?
The webcast is scheduled for November 13, 2025, at 9:00 a.m. Eastern Time.
Who will lead the webcast discussion?
Panna Sharma, President and CEO of Lantern Pharma, will lead the discussion during the webcast.
What will be discussed during the webcast?
The call will cover operating and financial results, along with guidance on upcoming milestones and challenges.
How can I participate in the webcast?
Participants can register in advance using the Zoom registration link provided for the event.
What is the core focus of Lantern Pharma?
Lantern Pharma focuses on utilizing AI to speed up cancer therapies' discovery and development while improving patient outcomes.